Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome

Gene mutations have not yet been included in the 2016 WHO classification and revised International Prognostic Scoring System (IPSS-R), which are now widely utilized to discriminate myelodysplastic syndrome (MDS) patients regarding risk of leukemia evolution and overall survival (OS). In this study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Hsin-An, Tsai, Cheng-Hong, Lin, Chien-Chin, Chou, Wen-Chien, Kuo, Yuan-Yeh, Liu, Chieh-Yu, Tseng, Mei-Hsuan, Peng, Yen-Ling, Liu, Ming-Chih, Liu, Chia-Wen, Liao, Xiu-Wen, Lin, Liang-In, Yao, Ming, Tang, Jih-Luh, Tien, Hwei-Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884776/
https://www.ncbi.nlm.nih.gov/pubmed/29618722
http://dx.doi.org/10.1038/s41408-018-0074-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884776/
https://www.ncbi.nlm.nih.gov/pubmed/29618722
http://dx.doi.org/10.1038/s41408-018-0074-7

Ejemplares similares